Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v6-EN
Language French English
Date Updated 2018-03-07 2018-01-15
Drug Identification Number 00761850 00761850
Brand name DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP
Common or Proper name DOPAMINE 0.8MG/ML DOPAMINE 0.8MG/ML
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients DOPAMINE HYDROCHLORIDE DEXTROSE DOPAMINE HYDROCHLORIDE DEXTROSE
Strength(s) .8MG 50MG .8MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL 250mL
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-12 2017-10-12
Actual start date 2017-10-12 2017-10-12
Estimated end date 2018-03-01 2018-02-12
Actual end date 2018-03-05
Shortage status Resolved Actual shortage
Company comments Supply available, allocated based on historical monthly usage. Please review important notice regarding Dopamine on Baxter.ca: http://www.baxter.ca/en/products-expertise/product-safety-information/important-product-updates.page Contact your local Baxter representative with questions. Supply is available but not enough to meet excess demand during the shortage period. Product allocation controls are in place to control excess demand.
Health Canada comments